Price Momentum and Market Performance
The stock closed at ₹133.15, up from the previous close of ₹120.60, with an intraday high of ₹141.05 and a low of ₹119.05. This rally brings Themis Medicare closer to its 52-week high of ₹147.99, a significant recovery from its 52-week low of ₹65.00. The price momentum is further validated by the stock’s returns outperforming the Sensex across short and medium-term periods. Over the past week, Themis Medicare gained 7.16% compared to the Sensex’s decline of 1.07%. The one-month return stands at 20.55%, while year-to-date gains are a robust 32.29%, contrasting sharply with the Sensex’s negative 10.66% YTD performance.
However, longer-term returns paint a more nuanced picture. Over three years, Themis Medicare has declined by 16.31%, whereas the Sensex has appreciated by 14.89%. The five-year returns for Themis Medicare are 28.49%, slightly lagging the Sensex’s 30.63%. Over a decade, the stock has delivered 131.57%, trailing the Sensex’s 163.19%. These figures suggest that while recent momentum is positive, the stock’s historical performance has been mixed relative to the broader market.
Technical Indicator Analysis
The technical landscape for Themis Medicare has improved markedly, with several key indicators signalling bullish momentum. The Moving Average Convergence Divergence (MACD) indicator is bullish on the weekly chart and mildly bullish on the monthly chart, indicating strengthening upward momentum in both intermediate and longer-term trends. The Relative Strength Index (RSI), however, remains neutral with no clear signal on weekly or monthly timeframes, suggesting the stock is not yet overbought and retains room for further upside.
Bollinger Bands reinforce this positive outlook, showing bullish signals on both weekly and monthly charts. This suggests that price volatility is expanding upwards, often a precursor to sustained rallies. Daily moving averages also support the bullish case, with the stock price trading above key averages, confirming short-term strength.
Contrastingly, the Know Sure Thing (KST) indicator presents a mixed view: mildly bearish on the weekly chart but mildly bullish on the monthly chart. This divergence indicates some short-term caution amid longer-term optimism. The Dow Theory aligns with this, showing mildly bullish trends on both weekly and monthly scales, reinforcing the overall positive technical sentiment.
On-balance volume (OBV) remains flat with no discernible trend on weekly or monthly charts, implying that volume has not decisively confirmed the price moves yet. This could be an area to monitor for confirmation of sustained buying interest.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Mojo Score and Rating Update
Themis Medicare’s MarketsMOJO score currently stands at 31.0, reflecting a Sell rating. This is an improvement from the previous Strong Sell grade assigned on 7 Sep 2026, signalling a modest upgrade in the stock’s outlook. The micro-cap classification underscores the stock’s relatively small market capitalisation, which often entails higher volatility and risk. Investors should weigh these factors carefully when considering exposure.
Sector and Industry Context
Operating within the Pharmaceuticals & Biotechnology sector, Themis Medicare is part of an industry that has seen mixed fortunes amid evolving regulatory landscapes and innovation cycles. The sector’s performance often hinges on product pipelines, approvals, and broader healthcare trends. The stock’s recent technical improvements may reflect positive developments or market sentiment shifts specific to the company or sector.
Comparative Technical Trends
The shift from mildly bullish to bullish technical trends is significant. Weekly technical trends now favour buyers more strongly, supported by bullish MACD and Bollinger Bands. The daily moving averages confirm short-term momentum, while monthly indicators suggest a cautiously optimistic longer-term outlook. The mild bearishness in the weekly KST indicator warrants attention, as it may signal short-term profit-taking or consolidation before further advances.
Investors should also note the absence of strong volume confirmation via OBV, which could imply that the recent price gains are not yet fully supported by institutional buying. This aspect may temper enthusiasm until volume trends align with price action.
Why settle for Themis Medicare Ltd? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Investor Takeaways and Outlook
Themis Medicare’s recent technical upgrades and price momentum suggest a potential inflection point for the stock. The bullish signals from MACD, Bollinger Bands, and moving averages indicate that the stock could continue its upward trajectory in the near term. However, the neutral RSI and lack of volume confirmation advise caution, as the rally may require stronger institutional support to sustain.
Given the micro-cap status and mixed longer-term returns, investors should consider their risk tolerance carefully. The upgrade from Strong Sell to Sell rating by MarketsMOJO reflects improving fundamentals or sentiment but does not yet signal a definitive turnaround. Monitoring upcoming quarterly results, sector developments, and volume trends will be crucial for validating this positive momentum.
In summary, Themis Medicare Ltd is showing encouraging signs of technical strength after a period of subdued performance. The stock’s outperformance relative to the Sensex in recent months adds to the positive narrative, although longer-term investors should remain vigilant given historical volatility and sector dynamics.
Summary of Key Technical Metrics:
- Current Price: ₹133.15 (up 10.41% on 8 Sep 2026)
- 52-Week Range: ₹65.00 - ₹147.99
- MACD: Weekly Bullish, Monthly Mildly Bullish
- RSI: No Signal (Weekly & Monthly)
- Bollinger Bands: Bullish (Weekly & Monthly)
- Moving Averages: Daily Bullish
- KST: Weekly Mildly Bearish, Monthly Mildly Bullish
- Dow Theory: Mildly Bullish (Weekly & Monthly)
- OBV: No Trend (Weekly & Monthly)
- Mojo Score: 31.0 (Sell, upgraded from Strong Sell)
Investors should continue to monitor these indicators alongside fundamental developments to gauge the sustainability of the current bullish momentum.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
